Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AT-004 by Arctic Therapeutics ehf for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
AT-004 is under clinical development by Arctic Therapeutics ehf and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According...
AT-004 by Arctic Therapeutics ehf for Rosacea: Likelihood of Approval
AT-004 is under clinical development by Arctic Therapeutics ehf and currently in Phase II for Rosacea. According to GlobalData, Phase...
AT-004 by Arctic Therapeutics ehf for Acne Vulgaris: Likelihood of Approval
AT-004 is under clinical development by Arctic Therapeutics ehf and currently in Phase II for Acne Vulgaris. According to GlobalData,...
AT-004 by Arctic Therapeutics ehf for Psoriasis: Likelihood of Approval
AT-004 is under clinical development by Arctic Therapeutics ehf and currently in Phase II for Psoriasis. According to GlobalData, Phase...
AT-002 by Arctic Therapeutics ehf for Uveitis: Likelihood of Approval
AT-002 is under clinical development by Arctic Therapeutics ehf and currently in Phase I for Uveitis. According to GlobalData, Phase...
AT-002 by Arctic Therapeutics ehf for Dermatomyositis: Likelihood of Approval
AT-002 is under clinical development by Arctic Therapeutics ehf and currently in Phase I for Dermatomyositis. According to GlobalData, Phase...
AT-003 by Arctic Therapeutics ehf for Multiple Sclerosis: Likelihood of Approval
AT-003 is under clinical development by Arctic Therapeutics ehf and currently in Phase II for Multiple Sclerosis. According to GlobalData,...
AT-003 by Arctic Therapeutics ehf for Parkinson's Disease: Likelihood of Approval
AT-003 is under clinical development by Arctic Therapeutics ehf and currently in Phase II for Parkinson's Disease. According to GlobalData,...
AT-003 by Arctic Therapeutics ehf for Rheumatoid Arthritis: Likelihood of Approval
AT-003 is under clinical development by Arctic Therapeutics ehf and currently in Phase II for Rheumatoid Arthritis. According to GlobalData,...
AT-003 by Arctic Therapeutics ehf for Systemic Lupus Erythematosus: Likelihood of Approval
AT-003 is under clinical development by Arctic Therapeutics ehf and currently in Phase II for Systemic Lupus Erythematosus. According to...